logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

    Article - En anglais

    This study examined the cost-effectiveness of adding a varicella vaccine to an existing childhood immunisation schedule relative to a counterfactual where the varicella vaccine is available on a user-pays basis (the current New Zealand situation).

    The costs and consequences of chickenpox in an annual cohort of 57,200,15-month old children were simulated for a 30-year period.

    The cohort simulation design captures the phasing-in'effects of routine varicella vaccination on the population.

    From a health care payer's perspective (medical costs only) every dollar invested in a vaccination programme would return NZ $0.67.

    However, from a societal point of view (which includes the value of work-loss), a vaccination programme would return NZ $2.79 for every dollar invested.

    To implement a varicella vaccination programme covering 80% of 15-month old children in New Zealand would add more than NZ $1 million in net direct (health care) costs each year.

    However, the indirect cost savings from reduced losses of work-time exceed NZ $2 million annually.

    The net average health care cost per child vaccinated over the 30-year modelling period was $54 whereas the cost-savings from work-loss averted averaged $101 per child vaccinated.

    Total cost-savings to society of $47 per child vaccinated, on average, could be gained from a vaccination programme. (...)

    Mots-clés Pascal : Varicelle, Virose, Infection, Nourrisson, Homme, Prévention, Vaccination, Efficacité, Evaluation, Programme sanitaire, Analyse coût efficacité, Coût variable, Coût fixe, Economie santé, Nouvelle Zélande, Océanie, Epidémiologie

    Mots-clés Pascal anglais : Varicella, Viral disease, Infection, Infant, Human, Prevention, Vaccination, Efficiency, Evaluation, Sanitary program, Cost efficiency analysis, Variable cost, Fixed cost, Health economy, New Zealand, Oceania, Epidemiology

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0394181

    Code Inist : 002B05C02B. Création : 22/03/2000.